Ultrasound-Guided Carpal Tunnel Release vs Open Release: What the 2026 Evidence Shows

Last updated: November 3, 2026.

Disclaimer: This article is for general education only. It is not medical advice and does not replace an assessment by a qualified surgeon. The Minor Surgery Center does not offer ultrasound-guided carpal tunnel release. This article summarizes published research so readers can understand the options and ask informed questions. Several of the studies described were sponsored by device manufacturers, which we note where relevant. Talk to your own surgeon about which technique is right for you.

Quick answer: Ultrasound-guided carpal tunnel release is a minimally invasive way to cut the transverse carpal ligament through a tiny wrist incision (about 5 mm), using live ultrasound to see inside the hand instead of opening the palm. Studies published in 2026, including a registry of 1,082 hands and a 2-year randomized trial, found symptom relief similar to open or mini-open release, with less early incision pain and a faster return to daily activities. Open release is still the standard, best-studied technique with the longest track record. Long-term head-to-head evidence for the ultrasound-guided approach is still limited (Smith et al., 2026; Sonex Health, June 2026; Korenblit et al., 2026).

Key takeaways

• Same goal, different route: both open and ultrasound-guided release relieve pressure on the median nerve by cutting the same ligament. The difference is how the surgeon reaches and sees it.
• Smaller incision: in the MISSION registry, the average wrist incision for ultrasound-guided release was about 5 mm, and 90% of cases needed no stitches (Sonex Health, June 2026).
• Faster early recovery: MISSION patients resumed normal activities after a median of 3 days and returned to work after a median of 4 days (Sonex Health, June 2026).
• Similar long-term relief: a 2-year randomized trial found both ultrasound-guided and mini-open release gave lasting improvements in symptoms, pain and function. The ultrasound group had less incision pain in the first few weeks (Smith et al., 2026).
• Evidence gaps remain: many ultrasound-guided studies are industry-sponsored, and long-term head-to-head data are limited. No major guideline yet makes technique-specific recommendations for ultrasound-guided release (Korenblit et al., 2026).
• Open release is still a strong option: it lets the surgeon see the ligament and nerve directly, and the NHS says carpal tunnel surgery "usually cures" the condition (NHS).

What is ultrasound-guided carpal tunnel release?

Ultrasound-guided carpal tunnel release (often shortened to UGCTR or CTR-US) is a procedure in which a surgeon uses real-time ultrasound imaging to guide a small device that cuts the transverse carpal ligament through a tiny incision, usually at the wrist crease. It is one of several minimally invasive ways to do carpal tunnel release (Korenblit et al., 2026).

To understand it, it helps to know what carpal tunnel syndrome is. The carpal tunnel is a narrow passage in the wrist. Its roof is a tough band of tissue called the transverse carpal ligament. The median nerve runs through the tunnel. When pressure builds up inside it, the nerve gets squeezed, causing numbness, tingling, night pain and weakness in the thumb, index and middle fingers. (Not sure if that's you? See how to know if you have carpal tunnel.)

Every form of carpal tunnel surgery works the same way: it divides the transverse carpal ligament to make more room for the nerve. What changes between techniques is how the surgeon reaches and sees the ligament:

• Open release: the surgeon makes an incision in the palm and sees the ligament directly.
• Mini-open release: a shorter palm incision, still with a direct view.
• Endoscopic release: a small camera passed through one or two small portals.
• Ultrasound-guided release: no direct view or camera. The surgeon watches the ligament, nerve, arteries and tendons on an ultrasound screen while a device inserted through a tiny incision cuts the ligament.

How is ultrasound-guided release different from open release?

The main differences are incision size, how the surgeon sees the anatomy, the anesthesia used and how quickly most people get back to daily activities.

Open carpal tunnel release

• Incision: a cut in the palm, typically one to a few centimetres. In the MISSION registry, open-release incisions averaged 16.5 mm (Sonex Health, January 2026).
• Visualization: direct. The surgeon can see the ligament, nerve and surrounding structures.
• Anesthesia: often a local anesthetic injection. The NHS describes it as about a 20-minute operation under local anesthetic, with no overnight stay (NHS).
• Closure: stitches.
• Recovery: the NHS says it can take about a month to return to normal activities (NHS). Some people have tenderness along the palm scar for several weeks.
• Track record: decades of use, with the largest body of evidence. It is often preferred for revision surgery, unusual anatomy or when another problem in the wrist needs to be addressed.

Ultrasound-guided carpal tunnel release

• Incision: about 5 mm, usually at the wrist rather than the palm. In MISSION, 90% of cases closed without stitches (Sonex Health, June 2026).
• Visualization: indirect, through real-time ultrasound. This depends heavily on the operator's ultrasound skill (Korenblit et al., 2026).
• Anesthesia: usually local anesthetic only. In MISSION, 82.1% of ultrasound-guided procedures used local anesthesia alone (often called WALANT: wide-awake local anesthesia, no tourniquet) (Sonex Health, June 2026).
• Setting: often an office or clinic procedure room rather than an operating room.
• Recovery: most studies report a return to daily activities within days, not weeks (details below).
• Track record: newer, with shorter follow-up and fewer independent studies.

What does the major guideline say?

The American Academy of Orthopaedic Surgeons' 2024 carpal tunnel guideline gives a strong recommendation that there is no difference in patient-reported outcomes between mini-open and endoscopic release, and that local anesthesia alone can be used for carpal tunnel release. The guideline summary does not make a recommendation about ultrasound-guided release (AAOS, 2024). A 2026 review likewise found that no guideline has issued technique-specific recommendations for ultrasound-guided release (Korenblit et al., 2026).

What does the 2026 research show?

Three 2026 publications and one 2026 review added the most to the evidence: the 6-month MISSION registry results, a 2-year randomized trial in a military health system, the final 2-year ROBUST results and a review of all minimally invasive techniques.

The MISSION registry: 1,082 hands at 6 months

MISSION is a prospective, multicentre U.S. registry of patients treated in routine practice with one ultrasound-guided device (UltraGuideCTR). The 6-month results were published in the Journal of Hand Surgery Global Online in 2026 (PubMed). As summarized by the device maker (Sonex Health, June 2026):

• Size: 887 patients and 1,082 hands at 22 U.S. sites.
• Return to normal activities: median 3 days.
• Return to work: median 4 days.
• Satisfaction: 89.9% of treated hands at 6 months.
• Symptoms, function and pain: improved and stayed significantly better than before treatment at 6 months.
• Both hands at once: 22% of patients had both hands treated in the same session, with results described as comparable to one-hand procedures.
• Incision and closure: mean incision about 5 mm; 90% closed without stitches.
• Anesthesia: 82.1% local anesthesia only.
• Safety: no intraoperative complications or serious adverse events were reported.

Important context: MISSION is sponsored by Sonex Health, the maker of the device. A registry tracks outcomes in real-world practice, but it does not randomly assign patients to different treatments, so it can't prove one technique is better than another.

MISSION's early comparison with open release

The MISSION registry also enrolled patients treated with open release. An earlier 3-month analysis of more than 1,400 enrolled patients compared the two. As reported by the device maker (Sonex Health, January 2026):

• Local anesthesia only: 84.8% ultrasound-guided vs 19.1% open
• Incision length: 5.2 mm vs 16.5 mm
• Stitches needed: 14.6% vs 100%
• Opioid use after the procedure: 10.2% vs 49.1%
• Complete resolution of wound sensitivity and pain at 3 months: 60.7% vs 22.8%
• Symptom and function scores: statistically favoured ultrasound-guided release

The authors concluded that both techniques are safe and effective. Because patients weren't randomized, differences between the groups (such as the setting, anesthesia choice or patient selection) could explain some of the gap.

The 2-year randomized trial in the U.S. military health system

This is the strongest type of evidence on the list, because patients were randomly assigned to a technique. Smith and colleagues published 2-year results in the Journal of Hand Surgery Global Online (2026; 8: 101078) (Medical Dialogues summary; PubMed).

• Design: single-site randomized controlled trial comparing ultrasound-guided release (done in a clinic procedure room) with mini-open release.
• Patients: 41 military beneficiaries (21 ultrasound-guided, 20 mini-open). Mean age 49.5; 58.5% women; 41.5% active-duty.
• Follow-up: 100% at 2 years.
• Results: both groups had clinically meaningful improvements in pain, symptoms and function, and those improvements lasted to 2 years.
• Early recovery: the ultrasound-guided group reported less incision pain during the first 4 weeks and less incision pain that limited function during the first 3 weeks.
• Complications: one infection, in the ultrasound-guided group.

Important context: with only 41 patients at a single centre, the trial is small. It was designed around short-term outcomes, so it can't rule out rare complications or small long-term differences.

ROBUST: final 2-year results from office-based procedures

ROBUST is a prospective, multicentre study of office-based ultrasound-guided release. Its final 2-year results were published in Plastic and Reconstructive Surgery – Global Open in 2026. As reported by the device maker (Sonex Health, September 2026):

• Size: 149 patients and 226 hands at 7 U.S. centres (6 private practices and 1 academic centre). 52% had both hands treated at once.
• Follow-up: more than 92% completed 2-year assessments.
• Setting and anesthesia: all procedures in a clinic with local anesthesia only.
• Recovery: return to activities at 2 days and to work at 4 days.
• Satisfaction: 95.7% at 2 years.
• Revisions: no revisions for persistent or recurrent symptoms.

Important context: ROBUST had no comparison group, and Sonex Health sponsored it.

The big-picture 2026 review

A narrative review by Korenblit and colleagues in the Journal of Clinical Medicine (August 2026) grouped minimally invasive carpal tunnel release into eight techniques by how the ligament is cut (Korenblit et al., 2026):

• Endoscopic: single-portal and dual-portal.
• Ultrasound-guided: retractable retrograde blade, hook-knife, thread-loop, antegrade blade, pinhole scalpel and needle-knife.

Its main conclusions:

• Return to work sooner is the most consistent benefit of minimally invasive techniques.
• The retractable retrograde blade is the most widely adopted ultrasound-guided technique, with a randomized trial supporting outcomes comparable to mini-open release.
• Hook-knife and thread-loop techniques show feasibility and lasting results, but most experience comes from a few high-volume operators.
• Antegrade blade, pinhole and needle-knife techniques have limited evidence.
• Complications: ultrasound-guided techniques had complication and reoperation rates comparable to open release in pooled data, but long-term data are lacking.
• Evidence limits: there are no randomized head-to-head trials of endoscopic vs ultrasound-guided release. Many ultrasound-guided studies come from a single operator or centre, and industry sponsorship is common.

If you've seen "thread" or "micro-knife" release mentioned online, those are among these ultrasound-guided variations. See our thread vs micro-knife carpal tunnel release comparison.

Is ultrasound-guided carpal tunnel release safe?

Published studies report low complication rates, but safety depends heavily on the operator's experience and on the patient's anatomy.

• Learning curve: the 2026 review reports published thresholds of roughly 30 procedures for surgeons with musculoskeletal ultrasound experience and about 50 for those without. It recommends cadaver training before independent practice (Korenblit et al., 2026).
• Anatomy matters: variations such as a motor branch of the median nerve that crosses through the ligament, a split (bifid) median nerve or thick overlying muscle can raise the risk in percutaneous approaches. Careful ultrasound mapping before cutting is key (Korenblit et al., 2026).
• Incomplete release: with any technique, if the ligament isn't fully divided, symptoms can persist. This is one reason open release is often preferred for revision surgery. (Read more about why carpal tunnel symptoms can come back after surgery.)
• Reported events: MISSION reported no intraoperative complications or serious adverse events at 6 months (Sonex Health, June 2026). The 2-year randomized trial reported one infection in the ultrasound-guided group (Smith et al., 2026).

How fast is recovery after ultrasound-guided vs open release?

Ultrasound-guided studies consistently report a return to daily activities and work within a few days, while open release usually means a few weeks before normal activities.

• Ultrasound-guided (MISSION): median 3 days to normal activities and 4 days to work (Sonex Health, June 2026).
• Ultrasound-guided (ROBUST): 2 days to activities and 4 days to work (Sonex Health, September 2026).
• Ultrasound-guided (multicentre review of 544 patients, ASSH 2023 poster): median 3 days to work, with 87.8% back by day 10 (Diagnostic Imaging).
• Open release: about a month to return to normal activities, according to the NHS (NHS).

Keep in mind:

• Nerve recovery is a separate clock. Whichever technique is used, numbness and grip strength can take weeks to months to improve, especially if the nerve was badly compressed for a long time. A small incision speeds wound healing, not nerve healing.
• Your job matters. Desk workers and manual labourers often have different return-to-work timelines. See return to work after carpal tunnel: desk job vs manual labour and carpal tunnel surgery recovery time off work.
• By the 1- to 2-year mark, results tend to converge. In the randomized trial, both groups had similar, lasting improvements by 2 years (Smith et al., 2026).

Can both hands be treated at the same time?

Some ultrasound-guided studies treated both hands in the same session, with outcomes reported as similar to one-hand procedures. In MISSION, 22% of patients had both hands done at once, and in ROBUST, 52% did (Sonex Health, June 2026; Sonex Health, September 2026).

With any technique, treating both hands at once means managing two healing hands at the same time, which can make daily tasks harder in the first days. Whether it makes sense for you depends on your symptoms, your daily needs and your surgeon's advice. Learn more about bilateral carpal tunnel syndrome.

What about the "needle-knife" technique?

Needle-knife release is a less-studied ultrasound-guided method that cuts the ligament with a fine needle-shaped blade. A small 2026 randomized trial from China compared it with a steroid injection in 27 patients (32 wrists) with mild-to-moderate carpal tunnel syndrome (Li et al., 2026):

• At 3 months, the needle-knife group had better numbness scores and better symptom severity scores than the steroid group.
• No complications were reported.
• The authors noted important limits: a small sample, only 3 months of follow-up, and that the needle-knife divides the ligament less completely than open surgery, so results may be weaker in severe cases and recurrence risk is unknown.

This trial compared the needle-knife with an injection, not with open release, so it doesn't tell us how the two surgical approaches compare.

Who might be a candidate for each technique?

There's no single "best" technique for everyone. The right choice depends on your anatomy, how severe your condition is, whether you've had surgery before and your surgeon's experience. (See mild vs moderate vs severe carpal tunnel.)

Situations where open release is often preferred, based on the review and standard practice (Korenblit et al., 2026):

• Revision surgery after a previous release
• Unusual anatomy that needs to be seen directly
• A previous wrist fracture or trauma
• A mass, cyst or significant tendon inflammation that also needs treatment
• A surgeon who is most experienced with open technique

Situations where ultrasound-guided release may appeal, if a qualified provider is available:

• Wanting a very small incision and minimal scar
• Needing to get back to work or daily activities quickly
• Preferring a procedure under local anesthetic in an office setting
• Wanting both hands treated in one session (discuss with the surgeon)
• Anatomy that is clearly visible on ultrasound

Is ultrasound-guided carpal tunnel release available in Canada and covered by OHIP?

The large published studies above were done in the United States, and availability in Canada is limited. If you're considering it, ask the provider:

• Is the procedure covered by OHIP, or are there extra fees?
• How many ultrasound-guided releases have you performed?
• What device or technique do you use?
• What happens if the ligament can't be fully released or the anatomy isn't clear on ultrasound?
• What follow-up is included?

Standard carpal tunnel release is OHIP-covered in Ontario. At The Minor Surgery Center, our board-certified plastic and reconstructive surgeons perform carpal tunnel release under local anesthetic, with no referral needed and same-day discharge. We do not offer ultrasound-guided release. Learn more about carpal tunnel surgery in Toronto, or find us in Vaughan, Oakville and our other GTA clinics. For timelines, see carpal tunnel surgery wait times in Ontario.

Do you need surgery at all?

Not always. The NHS lists non-surgical options such as a wrist splint worn at night (improvement can take up to 6 weeks) and cutting back on activities that trigger symptoms, and notes that carpal tunnel syndrome sometimes gets better by itself within a few months, especially when it's linked to pregnancy (NHS). The AAOS guideline notes that corticosteroid injections don't provide long-term improvement (AAOS, 2024), and the NHS says surgery is considered when symptoms get worse and other treatments haven't worked (NHS). See our guide to carpal tunnel surgery alternatives.

See a doctor sooner if you have:

• Constant numbness rather than numbness that comes and goes
• Weakness or dropping things
• Wasting of the muscle at the base of the thumb
• Symptoms that keep you awake most nights
• No improvement after about 6 weeks of night splinting

Frequently asked questions

What is ultrasound-guided carpal tunnel release?

It is a minimally invasive procedure in which a surgeon uses live ultrasound to guide a small device that cuts the transverse carpal ligament through a tiny wrist incision, usually about 5 mm. It relieves pressure on the median nerve, just like open surgery.

Is ultrasound-guided carpal tunnel release better than open surgery?

Not clearly better overall. Studies show similar long-term symptom relief, with less early incision pain and a faster return to daily activities after ultrasound-guided release. Open release has a longer track record and is often preferred for revisions or unusual anatomy.

How long is recovery after ultrasound-guided carpal tunnel release?

In the 2026 MISSION registry, patients resumed normal activities after a median of 3 days and returned to work after a median of 4 days. Nerve recovery (numbness and grip strength) can still take weeks to months.

Does ultrasound-guided carpal tunnel release leave a scar?

It leaves a much smaller one. Incisions averaged about 5 mm in MISSION, compared with 16.5 mm for open release, and most closed without stitches.

Is ultrasound-guided carpal tunnel release done under general anesthesia?

Usually not. In MISSION, 82.1% of ultrasound-guided procedures used local anesthesia only. The AAOS guideline says local anesthesia alone can be used for carpal tunnel release in general.

What are the risks of ultrasound-guided carpal tunnel release?

Reported complication rates are low, but risks include incomplete release, infection and, rarely, nerve or vessel injury. Results depend heavily on the surgeon's ultrasound experience and the patient's anatomy.

Is ultrasound-guided carpal tunnel release covered by OHIP?

Coverage may vary, so ask the provider directly. Standard carpal tunnel release is OHIP-covered in Ontario.

Does The Minor Surgery Center offer ultrasound-guided carpal tunnel release?

No. Our surgeons perform carpal tunnel release under local anesthetic, OHIP-covered, with no referral needed. This article is educational and summarizes published research.

Can carpal tunnel come back after ultrasound-guided release?

Recurrence can happen after any technique, especially if the ligament isn't fully divided. ROBUST reported no revisions for persistent or recurrent symptoms at 2 years, but long-term comparative data are still limited.

What's the difference between endoscopic and ultrasound-guided release?

Endoscopic release uses a small camera inside the tunnel. Ultrasound-guided release uses ultrasound images from outside the skin. Both use small incisions. There are no randomized trials directly comparing the two.

References

All sources were accessed on November 3, 2026.

1. Smith MS, et al. "Carpal Tunnel Release Using Ultrasound Guidance: Two-Year Outcomes of a Randomized Controlled Trial Within the Military." Journal of Hand Surgery Global Online. 2026;8:101078. PubMed. Summary: Medical Dialogues, October 18, 2026.
2. "Real-World Outcomes of Ultrasound-Guided Carpal Tunnel Release in 1,082 Hands: 6-Month Results From the MISSION Registry." Journal of Hand Surgery Global Online. 2026. PubMed.
3. Sonex Health. "Sonex Health Announces Data From Largest-Ever U.S. Study Proving UltraGuideCTR Delivers Compelling Results for Carpal Tunnel Patients." Press release, June 9, 2026. (Manufacturer source.)
4. Sonex Health. "Sonex Health Announces Publication of Largest Multi-Center Study Comparing Ultrasound-Guided Carpal Tunnel Release to Open Carpal Tunnel Release." Press release, January 22, 2026. (Manufacturer source.)
5. Sonex Health. "Sonex Health Announces Publication of Longest and Largest Study of Office-Based Ultrasound-Guided Carpal Tunnel Release." Press release, September 2, 2026. (Manufacturer source; ROBUST final 2-year results.)
6. Korenblit M, Haas EJ, Esch EM, Orfahli L, Mares O, Greyson M. "A Mechanism-Based Classification and Review of Endoscopic and Ultrasound-Guided Carpal Tunnel Release." Journal of Clinical Medicine. 2026;15(16):6130. Published August 7, 2026.
7. Li YN, Li SL, Zhou QY. "Comparison of ultrasound-guided needle-knife release of the transverse carpal ligament with glucocorticoid injection in the treatment of carpal tunnel syndrome: a randomized trial." Quantitative Imaging in Medicine and Surgery. 2026;16(7):529.
8. American Academy of Orthopaedic Surgeons. "Management of Carpal Tunnel Syndrome Clinical Practice Guideline (2024) – summary infographic."
9. NHS. "Carpal tunnel syndrome – Treatment."
10. Diagnostic Imaging. "Multicenter Study Shows Benefits of Ultrasound-Guided Carpal Tunnel Release." October 6, 2023 (ASSH 2023 poster, 544 patients).

‍